dimethyldioctadecylammonium has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerley, C; Cassady, R; Chonn, A; Griesenbach, U; Hannam, V; O'Brodovich, H; Olek, K; Post, M; Tanswell, AK | 1 |
| Belcastro, R; Downey, G; Hannam, V; Hu, J; Koehler, DR; Post, M; Steer, B; Tanswell, AK; Wen, Y | 1 |
2 other study(ies) available for dimethyldioctadecylammonium and Cystic Fibrosis
| Article | Year |
|---|---|
Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy.
Topics: Analysis of Variance; Animals; Autoradiography; Bronchi; Cations; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Epithelial Cells; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Immunohistochemistry; Injections, Intravenous; Liposomes; Mice; Mice, Inbred Strains; Phosphatidylethanolamines; Pulmonary Alveoli; Quaternary Ammonium Compounds; Trachea | 1998 |
Targeting transgene expression for cystic fibrosis gene therapy.
Topics: Animals; Cystic Fibrosis; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glycerophospholipids; Humans; Injections, Intravenous; Keratins; Lac Operon; Liposomes; Mice; Mice, Inbred Strains; Organ Specificity; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Surface-Active Agents; Tissue Distribution; Transgenes | 2001 |